Novo Nordisk shares jump 8% on U.S. Wegovy pill approval
Shares of Novo Nordisk surged nearly 8% after the U.S. FDA approved its Wegovy weight-loss pill. The landmark decision marks a major expansion for the obesity drug market.
Shares of Novo Nordisk surged nearly 8% after the U.S. FDA approved its Wegovy weight-loss pill. The landmark decision marks a major expansion for the obesity drug market.
U.S. regulators have approved the Wegovy pill for weight loss, a major development in pharmaceutical treatment. Learn about the details and potential impact of this new drug.
New data shows Eli Lilly's oral weight-loss drug successfully maintains weight reduction after patients switch from injectable medications. A breakthrough for chronic obesity management.
Former VP Mike Pence demands Health Secretary Robert F. Kennedy Jr. resign, citing failure on pro-life promises. The controversy centers on a safety review of the abortion pill mifepristone.
Final arguments are being heard in a Montreal court challenge against Quebec's law requiring protesters to stay 50 metres from abortion clinics. The case tests the balance between access and protest rights.
A new report details the extreme dangers Afghan women face seeking abortions under Taliban rule, including horrific traditional methods. Read the full story on the human rights crisis.
Addiction experts warn Ontario's unregulated safer supply program fuels diversion and addiction via electronic pill mills. Learn about the crisis and calls for action.
Chris Selley explores the complex reactions to late-term abortion realities in Canada. Discover why this medical procedure sparks intense debate even among pro-choice advocates.
South Carolina legislators are examining what could become the most restrictive abortion legislation in the United States as opponents continue challenging limits. Stay informed on this developing story.